Clinical Trials for Peripheral T Cell Lymphoma

Find clinical trials for peripheral t cell lymphoma. Discover research opportunities and treatment options in your area.

34 Active Trials Found

Showing 34 trials on this page

Page 1 of 2

A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers.

NCT ID: NCT06870487

This clinical trial is designed to investigate a new medicine called PF-08046032 for adults with advanced cancers, specifically certain types of lymphomas and solid tumors. The study aims to unders...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Barcelona, , Spain +8 more

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

NCT ID: NCT06072131

This clinical trial is studying two new treatment combinations for patients with a type of cancer called Peripheral T Cell Lymphoma (PTCL) that has just been diagnosed. The researchers want to find...

Recruiting

Phase: PHASE3 Type: interventional Locations: Zaragoza, , Spain, Houston, Texas, United States +68 more

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

NCT ID: NCT06131801

This clinical trial is studying how well venetoclax, a medication used to treat certain types of blood cancers like leukemia and lymphoma, works when the tablets are crushed and dissolved in liquid...

Recruiting

Type: observational Locations: Cincinnati, Ohio, United States

Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23)

NCT ID: NCT07032532

This clinical trial is studying a new medicine called golidocitinib, taken by mouth, to treat people who have just been diagnosed with a type of blood cancer called peripheral T-cell lymphoma (PTCL...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Guanzhou, Guangdong, China

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

NCT ID: NCT04068597

This clinical trial is looking at a new treatment called CCS1477 for patients with certain blood cancers, including Non-Hodgkin Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia, and higher-risk M...

Recruiting

Phase: PHASE1 Type: interventional Locations: Glasgow, , United Kingdom, Cardiff, , United Kingdom +25 more

GVM±R in Patients With Relapsed or Refractory Aggressive NHL.

NCT ID: NCT06244368

This clinical trial is looking at a new treatment called GVM±R for patients with aggressive non-Hodgkin's lymphoma (NHL) who have either not responded to previous treatments or have experienced a r...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, Tianjin, China

Tazemetostat Plus CHOP in 1L T-cell Lymphoma

NCT ID: NCT06692452

This clinical trial is investigating a new treatment option for patients with certain types of T-cell lymphoma, specifically looking at how well a drug called tazemetostat works when combined with ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States +2 more

Study of Lacutamab in Peripheral T-cell Lymphoma

NCT ID: NCT04984837

This clinical trial is studying a new treatment called Lacutamab for patients with certain types of Peripheral T-cell Lymphoma (PTCL) that have not responded to previous treatments. The trial aims ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Rouen, , France, Lyon, , France +77 more

A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study

NCT ID: NCT06630091

The GOLDEN Study is a clinical trial aimed at evaluating the safety and effectiveness of a new drug called golidocitinib for patients with a type of cancer known as Peripheral T Cell Lymphoma (PTCL...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma

NCT ID: NCT06151106

This clinical trial is studying the combination of two medications, Chidamide and Duvalisib, to see how effective and safe they are for treating patients with peripheral T-cell lymphoma (PTCL) that...

Recruiting

Phase: PHASE2 Type: interventional Locations: Xiamen, Fujian, China

Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma

NCT ID: NCT05958719

This clinical trial is studying a new treatment for patients who have not yet received any therapy for Nodal T-follicular Helper (TFH) Cell Lymphoma, a type of cancer affecting the lymphatic system...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, Tianjin, China

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

NCT ID: NCT06508463

This clinical trial is investigating a new treatment approach for patients with certain types of T-cell lymphoma, such as peripheral T-cell lymphoma and anaplastic large cell lymphoma. The treatmen...

Recruiting

Phase: PHASE1 Type: interventional Locations: Scottsdale, Arizona, United States, Rochester, Minnesota, United States

Linperlisib Combined With EZH2 Inhibitor in Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL)

NCT ID: NCT06712173

This clinical trial is looking at a new treatment for patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), a type of cancer that affects certain white blood cells known as T-cell...

Not yet recruiting

Phase: PHASE1 Type: interventional

AZD4205 in Relapsed or Refractory Peripheral T Cell Lymphoma (JACKPOT27)

NCT ID: NCT06511895

The JACKPOT27 clinical trial is studying a new oral medication called AZD4205 for patients with relapsed or refractory peripheral T cell lymphoma (PTCL), a type of cancer that affects the lymphatic...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chengdu, Sichuan, China, Hangzhou, Zhejiang, China +17 more

Phase 2 Study of AFM13 in Combination with AB-101 in Subjects with R/R HL and CD30+ PTCL

NCT ID: NCT05883449

This clinical trial, called AFM13-203, is studying a new treatment combining two drugs, AFM13 and AB-101, for patients with relapsed or refractory Hodgkin lymphoma (HL) and certain types of periphe...

Recruiting

Phase: PHASE2 Type: interventional Locations: Saint Louis, Missouri, United States, Philadelphia, Pennsylvania, United States +13 more

Evaluate the Safety and Clinical Activity of HH2853

NCT ID: NCT04390737

This clinical trial is studying a new medication called HH2853 to see how safe it is and how well it works for patients with certain types of cancers, including follicular lymphoma, epithelioid sar...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Jacksonville, Florida, United States +21 more

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

NCT ID: NCT04083495

This clinical trial is investigating a new treatment called ATLCAR.CD30 for patients with a type of cancer known as peripheral T cell lymphoma that has not responded to previous treatments. The stu...

Recruiting

Phase: PHASE2 Type: interventional Locations: Winston Salem, North Carolina, United States, Chapel Hill, North Carolina, United States

A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma

NCT ID: NCT04045470

This clinical trial is exploring a new way to treat cutaneous T-cell lymphoma and peripheral T-cell lymphoma, which are types of skin cancers. Researchers want to see if a small device that can rel...

Recruiting

Phase: NA Type: interventional Locations: Boston, Massachusetts, United States

A Phase II/III Study of Linperlisib Plus CHOP Versus CHOP in Patients With Newly Diagnosed Peripheral T Cell Lymphoma

NCT ID: NCT06548347

This clinical trial is looking at a new treatment combining a drug called Linperlisib with a standard chemotherapy regimen known as CHOP for adults who have just been diagnosed with Peripheral T Ce...

Not yet recruiting

Phase: PHASE2 Type: interventional

RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.

NCT ID: NCT06468267

This clinical trial is looking at a new treatment approach for patients with relapsed or refractory Peripheral T-Cell Lymphoma (PTCL), a type of cancer that affects a specific group of white blood ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions